AU774516C - Ionophore antibiotic formulations - Google Patents

Ionophore antibiotic formulations

Info

Publication number
AU774516C
AU774516C AU22419/00A AU2241900A AU774516C AU 774516 C AU774516 C AU 774516C AU 22419/00 A AU22419/00 A AU 22419/00A AU 2241900 A AU2241900 A AU 2241900A AU 774516 C AU774516 C AU 774516C
Authority
AU
Australia
Prior art keywords
antibiotic formulations
ionophore antibiotic
ionophore
formulations
antibiotic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU22419/00A
Other versions
AU2241900A (en
AU774516B2 (en
Inventor
Kim Ewing Melville Agnew
Lionel Barry Lowe
Derek George Moore
Kevin Charles Palmer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co NZ Ltd
Original Assignee
Eli Lilly and Co NZ Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU29075/99A external-priority patent/AU741614C/en
Application filed by Eli Lilly and Co NZ Ltd filed Critical Eli Lilly and Co NZ Ltd
Priority to AU22419/00A priority Critical patent/AU774516C/en
Publication of AU2241900A publication Critical patent/AU2241900A/en
Application granted granted Critical
Publication of AU774516B2 publication Critical patent/AU774516B2/en
Publication of AU774516C publication Critical patent/AU774516C/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

AU22419/00A 1995-07-14 2000-03-21 Ionophore antibiotic formulations Ceased AU774516C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU22419/00A AU774516C (en) 1995-07-14 2000-03-21 Ionophore antibiotic formulations

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
NZ272574 1995-07-14
NZ272940 1995-09-06
AU29075/99A AU741614C (en) 1995-07-14 1999-05-17 Ionophore antibiotic formulations
AU22419/00A AU774516C (en) 1995-07-14 2000-03-21 Ionophore antibiotic formulations

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
AU29075/99A Division AU741614C (en) 1995-07-14 1999-05-17 Ionophore antibiotic formulations

Publications (3)

Publication Number Publication Date
AU2241900A AU2241900A (en) 2000-06-01
AU774516B2 AU774516B2 (en) 2004-07-01
AU774516C true AU774516C (en) 2005-12-22

Family

ID=32660468

Family Applications (2)

Application Number Title Priority Date Filing Date
AU22419/00A Ceased AU774516C (en) 1995-07-14 2000-03-21 Ionophore antibiotic formulations
AU48043/01A Ceased AU774945C (en) 1995-07-14 2001-05-25 ionophore antibiotic formulations

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU48043/01A Ceased AU774945C (en) 1995-07-14 2001-05-25 ionophore antibiotic formulations

Country Status (1)

Country Link
AU (2) AU774516C (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5112604A (en) * 1989-09-01 1992-05-12 Riker Laboratories, Inc. Oral suspension formulation
EP0556057A1 (en) * 1992-02-14 1993-08-18 McNEIL-PPC, INC. Aqueous pharmaceutical suspension for pharmaceutical actives
EP0620001A1 (en) * 1993-04-16 1994-10-19 McNEIL-PPC, INC. Aqueous pharmaceutical suspension and process for preparation thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5112604A (en) * 1989-09-01 1992-05-12 Riker Laboratories, Inc. Oral suspension formulation
EP0556057A1 (en) * 1992-02-14 1993-08-18 McNEIL-PPC, INC. Aqueous pharmaceutical suspension for pharmaceutical actives
EP0620001A1 (en) * 1993-04-16 1994-10-19 McNEIL-PPC, INC. Aqueous pharmaceutical suspension and process for preparation thereof

Also Published As

Publication number Publication date
AU774945B2 (en) 2004-07-15
AU4804301A (en) 2001-09-27
AU2241900A (en) 2000-06-01
AU774516B2 (en) 2004-07-01
AU774945C (en) 2005-12-22

Similar Documents

Publication Publication Date Title
AU4665596A (en) Pyrazolylbenzoyl derivatives
AU5428096A (en) Oral 2-methyl-thieno-benzodiazepine formulation
AU4780896A (en) Core-board
AU7626596A (en) Oxymethoxy-3-aryl-pyrone derivatives
AU1030997A (en) Taphane
AU4086296A (en) Indolepiperidine derivatives
AU1195897A (en) Heteroarylcarboxamide derivatives
AU7053296A (en) Purin-6-one derivatives
AU4875296A (en) Isoxazolyl-benzoyl derivatives
AU5763596A (en) 2-ureido-benzamide derivatives
AU7265796A (en) Probiotically acting formulation
AU7265596A (en) Probiotically acting formulations
AU6191796A (en) Sulfonyl- or sulfinylbenzoylguanidine derivatives
AU7084796A (en) Diarylalkenylamine derivatives
AU5052296A (en) 4-indolylpiperazinyl derivatives
AU4547796A (en) Hexahydropyrazinoquinoline derivatives
AU4382896A (en) Acetylimidazobenzodiazepines
AU5698396A (en) Antibiotics
AU4211296A (en) 4-aminobenzoylguanidine derivatives
AU6929696A (en) Pyrazol-4-ylbenzoyl derivatives
AU6371196A (en) Ionophore antibiotic formulations
AU7415996A (en) Antibiotic macrolides
AU4547396A (en) Thioquinoline derivatives
AU3121095A (en) Antibiotic macrolides
AU6214896A (en) Alkenyl-benzoylguanidine derivatives

Legal Events

Date Code Title Description
MK1 Application lapsed section 142(2)(a) - no request for examination in relevant period
NA Applications received for extensions of time, section 223

Free format text: AN APPLICATION TO EXTEND THE TIME FROM 20001012 TO 20010612 IN WHICH TO REQUEST EXAMINATION HAS BEEN LODGED

NB Applications allowed - extensions of time section 223(2)

Free format text: THE TIME IN WHICH TO REQUEST EXAMINATION HAS BEEN EXTENDED TO 20010612

FGA Letters patent sealed or granted (standard patent)